VBL First-in-class MOSPD2 Antibodies Show Potential for Treatment for CNS Inflammation

NEXT STORY
MediWound Strengthens its NexoBrid European Presence with Additional Distribution Agreements
PREV STORY
Teleflex Announces Quarterly Dividend
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

uniQure Announces New Appointments to its Board of Directors

LEXINGTON, Mass. and AMSTERDAM, The Netherlands, June 13, 2018 (GLOBE NEWSWIRE) -- uniQure N.V. ...

author_avatar
NASDAQ Market News

Clearside Biomedical to Participate in 2018 JMP Securities Life Sciences Conference

ALPHARETTA, Ga., June 11, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical ...

author_avatar
NASDAQ Market News

ICU Medical, Inc. to Present at 35th Annual J.P. Morgan Healthcare Conference

SAN CLEMENTE, Calif., Jan. 06, 2017 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a ...

author_avatar
NASDAQ Market News